MarketInOut Stock Screener Log In | Sign Up
 

Lite Strategy Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Lite Strategy Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization36.18 mln
Float29.97 mln
Earnings Date11/13/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

27 / 100
Underperforming

ROE

-115
Deeply negative

ROA

-113
Deeply negative

Business Description

Lite Strategy Inc. is a San Diego-based drug development company working to bring new cancer treatments to patients. Founded in 2000 and previously operating as MEI Pharma Inc., the company adopted its current name in September 2025. Its work centers on advancing experimental therapies through clinical testing toward potential medical use.

Key Fundamentals

EPS-2.06
ROE-115
ROIC-22.90
ROA-113
EBITDA, mln-71.15
EV / EBITDA-0.60
EV / EBIT-0.60

Quote Details

Last 1.16
Change -0.03 (-2.52%)
Open 1.19
Volume 141,125
Turnover 163,705
Average Volume 549,636

Financial Ratios

Leverage Ratio1.03
Current Ratio5.75
Price / Book1.06
Price / Tangible Book3.08
PEG Ratio2.22

Financial Strength

Piotroski F-Score 2 / 9
Short Ratio0.21
Short % of Float0.62

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.87% 70 / 100   
1 Month -18.88% 19 / 100   
2 Months 12.62% 89 / 100   
6 Months -1.69% 49 / 100   
1 Year -37.63% 22 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog